Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis
  2. Kanai,Tapan; Hu, Zongyi; Yang,Renbin; Wu, Weimin; Wang, Ziqiu; Ma, Christopher D; Sanchez-Meza, Jaime; Law, Mansun; Houghton, Michael; Law, John Lokman; Logan, Michael; de Val, Natalia; Liang, T Jake
  3. Journal of Virology. 2022, Dec 15; e0178822.
  1. 2.   Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-(AuNP)-Au-198 nanoconstruct in prostate tumor-bearing mice
  2. Chanda, N.; Kan, P.; Watkinson, L. D.; Shukla, R.; Zambre, A.; Carmack, T. L.; Engelbrecht, H.; Lever, J. R.; Katti, K.; Fent, G. M.; Casteel, S. W.; Smith, C. J.; Miller, W. H.; Jurisson, S.; Boote, E.; Robertson, J. D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K. V.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2010, Apr; 6(2): 201-209.
  1. 3.   Association Energetics of Cross-Reactive and Specific Antibodies
  2. Mohan, S.; Kourentzi, K.; Schick, K. A.; Uehara, C.; Lipschultz, C. A.; Acchione, M.; DeSantis, M. E.; Smith-Gill, S. J.; Willson, R. C.
  3. Biochemistry. 2009 48(6): 1390-1398.
  1. 4.   In vitro efficacy of immuno-chemotherapy with anti-EGFR human fab-taxol conjugate on A431 epidermoid carcinoma cells
  2. Wang, X.; Zhu, J.; Zhao, P.; Jiao, Y. G.; Xu, N.; Grabinski, T.; Liu, C.; Miranti, C. K.; Fu, T.; Cao, B. B.
  3. Cancer Biology & Therapy. 2007, Jun; 6(6): 980-986.
  1. 5.   Cellular and tissue distribution of intravenously administered agalsidase alfa
  2. Murray, G. J.; Anver, M. R.; Kennedy, M. A.; Quirk, J. M.; Schiffmann, R.
  3. Molecular Genetics and Metabolism. 2007, Mar; 90(3): 307-312.
  1. 6.   Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097
  2. Das, K.; Sarafianos, S. G.; Clark, A. D.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Journal of Molecular Biology. 2007, Jan; 365(1): 77-89.
  1. 7.   Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning
  2. Zhang, M. Y.; Choudhry, V.; Sidorov, I. A.; Tenev, V.; Vu, B. K.; Choudhary, A.; Lu, H.; Stiegler, G. M.; Katinger, H. W. D.; Jiang, S.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Immunological Methods. 2006, Dec; 317(1-2): 21-30.
  1. 8.   Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs
  2. Prabakaran, P.; Gan, J. H.; Wu, Y. Q.; Zhang, M. Y.; Dimitrov, D. S.; Ji, X. H.
  3. Journal of Molecular Biology. 2006, MAR 17; 357(1): 82-99.
  1. 9.   HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site
  2. Himmel, D. M.; Sarafianos, S. G.; Dharmasena, S.; Hossain, M. M.; McCoy-Simandle, K.; Ilina, T.; Clark, A. D.; Knight, J. L.; Julias, J. G.; Clark, P. K.; Krogh-Jespersen, K.; Levy, R. M.; Hughes, S. H.; Parniak, M. A.; Arnold, E.
  3. Acs Chemical Biology. 2006 1(11): 702-712.
  1. 10.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 11.   Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: A new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains
  2. Himmel, D. M.; Das, K.; Clark, A. D.; Hughes, S. H.; Benjahad, A.; Oumouch, S.; Guillemont, J.; Coupa, S.; Poncelet, A.; Csoka, I.; Meyer, C.; Andries, K.; Nguyen, C. H.; Grierson, D. S.; Arnold, E.
  3. Journal of Medicinal Chemistry. 2005, DEC 1; 48(24): 7582-7591.
  1. 12.   Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope
  2. Darbha, R.; Phogat, S.; Labrijn, A. F.; Shu, Y.; Gu, Y. J.; Andrykovitch, M.; Zhang, M. Y.; Pantophlet, R.; Martin, L.; Vita, C.; Burton, D. R.; Dimitrov, D. S.; Ji, X. H.
  3. Biochemistry. 2004 43(6): 1410-1417.
  1. 13.   Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA
  2. Peletskaya, E. N.; Kogon, A. A.; Tuske, S.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2004 78(7): 3387-3397.
  1. 14.   Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades
  2. Zhang, M. Y.; Shu, Y.; Sidorov, I.; Dimitrov, D. S.
  3. Antiviral Research. 2004 61(3): 161-164.
  1. 15.   Tuning spectral properties of fullerenes by substitutional doping
  2. Xie, R. H.; Bryant, G. W.; Sun, G. Y.; Kar, T.; Chen, Z. F.; Smith, V. H.; Araki, Y.; Tagmatarchis, N.; Shinohara, H.; Ito, O.
  3. Physical Review B. 2004 69(20, Art. No. 201403):
  1. 16.   Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning
  2. Zhang, M. Y.; Shu, Y. U.; Rudolph, D.; Prabakaran, P.; Labrijn, A. F.; Zwick, M. B.; Lal, R. B.; Dimitrov, D. S.
  3. Journal of Molecular Biology. 2004 335(1): 209-219.
  1. 17.   Trapping HIV-1 reverse transcriptase before and after translocation on DNA
  2. Sarafianos, S. G.; Clark, A. D.; Tuske, S.; Squire, C. J.; Das, K.; Sheng, D. Q.; Ilankumaran, P.; Ramesha, A. R.; Kroth, H.; Sayer, J. M.; Jerina, D. M.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Journal of Biological Chemistry. 2003 278(18): 16280-16288.
  1. 18.   Combinatorial evolution of high-affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen
  2. Landon, L. A.; Peletskaya, E. N.; Glinsky, V. V.; Karasseva, N.; Quinn, T. P.; Deutscher, S. L.
  3. Journal of Protein Chemistry. 2003 22(2): 193-204.
  1. 19.   Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1
  2. Bouma, P.; Leavitt, M.; Zhang, P. F.; Sidorov, I. A.; Dimitrov, D. S.; Quinnan, G. V.
  3. Journal of Virology. 2003 77(14): 8061-8071.
  1. 20.   Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKASIII) from Plasmodium falciparum
  2. Waters, N. C.; Kopydlowski, K. M.; Guszczynski, T.; Wei, L.; Sellers, P.; Ferlan, J. T.; Lee, P. J.; Li, Z. Y.; Woodard, C. L.; Shallom, S.; Gardner, M. J.; Prigge, S. T.
  3. Molecular and Biochemical Parasitology. 2002 123(2): 85-94.
  1. 21.   Cyanovirin-N, a potent human immunodeficiency virus- inactivating protein, blocks both CD4-dependent and CD4- independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells
  2. Mori, T.; Boyd, M. R.
  3. Antimicrobial Agents and Chemotherapy. 2001 45(3): 664-672.
  1. 22.   Mutations of an epitope hot-spot residue alter rate limiting steps of antigen-antibody protein-protein associations
  2. Li, Y. L.; Lipschultz, C. A.; Mohan, S.; Smith-Gill, S. J.
  3. Biochemistry. 2001 40(7): 2011-2022.
  1. 23.   Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA : DNA
  2. Sarafianos, S. G.; Das, K.; Tantillo, C.; Clark, A. D.; Ding, J.; Whitcomb, J. M.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Embo Journal. 2001 20(6): 1449-1461.
  1. 24.   The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance
  2. Hsiou, Y.; Ding, J. P.; Das, K.; Clark, A. D.; Boyer, P. L.; Lewi, P.; Janssen, P. A. J.; Kleim, J. P.; Rosner, M.; Hughes, S. H.; Arnold, E.
  3. Journal of Molecular Biology. 2001 309(2): 437-445.
  1. 25.   Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
  2. Koh, C. Y.; Blazar, B. R.; George, T.; Welniak, L. A.; Capitini, C. M.; Raziuddin, A.; Murphy, W. J.; Bennett, M.
  3. Blood. 2001 97(10): 3132-3137.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel